Lessons learned and keys to success: Provider experiences during the implementation of virtual oncology tumor boards in the era of COVID-19
- PMID: 34994401
- PMCID: PMC9015483
- DOI: 10.1002/jso.26784
Lessons learned and keys to success: Provider experiences during the implementation of virtual oncology tumor boards in the era of COVID-19
Abstract
Background and objectives: The COVID-19 pandemic required rapid adaptation of multidisciplinary tumor board conferences to a virtual setting; however, there are little data describing the benefits and challenges of using such a platform.
Methods: An anonymous quality improvement survey was sent to participants of tumor board meetings at a large academic institution. Participants answered questions pertaining to the relative strengths and weaknesses of in-person and virtual settings.
Results: A total of 335 responses (23.3% response rate) were recorded, and 253 met inclusion criteria. Respondents represented 25 different tumor board meetings, with colorectal, breast, and liver (18.6%, 17.0%, and 13.0%, respectively) being the most commonly attended. Virtual tumor boards were equivalent to in-person across 9 of 10 domains queried, while a virtual format was preferred for participation in off-site tumor boards. The lack of networking opportunities was ranked by physicians to be a significant challenge of the virtual format. Consistent leadership and organization, engaged participation of all attendees, and upgrading technology infrastructure were considered critical for success of virtual meetings.
Conclusions: The implementation of virtual tumor board meetings has been associated with numerous challenges. However, improving several key aspects can improve participant satisfaction and ensure excellent patient care.
Keywords: COVID-19; MDT; multidisciplinary team; tumor board; virtual.
© 2022 Wiley Periodicals LLC.
Conflict of interest statement
The authors declare that there are no conflict of interests.
Figures




References
-
- Newman EA, Guest AB, Helvie MA, et al. Changes in surgical management resulting from case review at a breast cancer multidisciplinary tumor board. Cancer. 2006;107(10):2346‐2351. - PubMed
-
- Thenappan A, Halaweish I, Mody RJ, et al. Review at a multidisciplinary tumor board impacts critical management decisions of pediatric patients with cancer. Pediatr Blood Cancer. 2017;64(2):254‐258. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous